Study of Xuesaitong Soft Capsules after heart stent placement
Part of Heart & circulation clinical trials.
This trial tests whether Xuesaitong Soft Capsules can help people who recently had a heart attack or unstable angina and received a stent. It aims to see if adding this medicine improves recovery and reduces future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack (STEMI or NSTEMI) or unstable angina and got a stent within the last 4 weeks.
- You are between 18 and 80 years old.
- Your blood pressure is controlled (systolic under 180 mmHg and diastolic under 110 mmHg).
- You do not have a high bleeding risk, like recent stroke, bleeding disorder, or stomach ulcer.
- You do not have severe heart, liver, or kidney problems, or a history of certain irregular heartbeats or cancer.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you have not donated blood recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called MT1002 in people who have had a heart attack and are about to get a stent (PCI). The goal is to see if MT1002 helps prevent further heart problems.
This trial compares two types of stents that release medicine to help keep arteries open after an acute coronary syndrome event (often called a heart attack or unstable angina). It tests whether the standard short course of two blood-thinning medicines for one month is enough, and which stent strategy works best.
This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.
This trial tests whether implanting stents in non-obstructive, high-risk plaques (thin-capped fatty plaques) can prevent future heart attacks. It is for people who have already had treatment for a recent heart attack or unstable angina and have additional plaques that are not severely blocking blood flow but are vulnerable.
This trial tests if a traditional Chinese medicine, Tongxinluo, can help prevent the artery from narrowing again after a stent procedure in the brain or neck. It's for people who have had a stroke or are at risk and recently got a stent.
This trial tests whether Guanxinning Tablet, a Chinese herbal medicine, can improve blood flow in the tiny vessels of the heart after an acute heart attack (STEMI) treated with emergency angioplasty. The study measures heart function changes over 6 months using imaging.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.